Comparative secretome analysis of benign prostate hyperplasia and prostate cancer cell models

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of prostatic inflammation in the development and progression of benign and malignant diseases

  2017influential reference
• Using biological networks to integrate, visualize and analyze genomics data

  2016cited by this paper
• Protein Precipitation Using Ammonium Sulfate

  2016cited by this paper
• PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives

  2016influential reference
• Genomic, Proteomic, and Metabolomic Data Integration Strategies

  2015cited by this paper
• Stable isotope labelling methods in mass spectrometry-based quantitative proteomics.

  2015influential reference
• Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.

  2015cited by this paper
• Proteomics in Cancer Biomarkers Discovery: Challenges and Applications

  2015influential reference
• Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Involved in Inflammation by Negatively Regulating the NF-κB Pathway

  2015cited by this paper
• Androgen receptor: structure, role in prostate cancer and drug discovery

  2014influential reference
• Kallikreins as Biomarkers for Prostate Cancer

  2014cited by this paper
• Biomarkers of HIV-associated Cancer

  2014cited by this paper
• Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions.

  2014influential reference
• PSA and beyond: Biomarkers in prostate cancer

  2014influential reference
• New biomarkers in prostate cancer.

  2014influential reference
• Top‐down proteomics in health and disease: Challenges and opportunities

  2014cited by this paper
• Proteomics biomarkers for non-small cell lung cancer.

  2014cited by this paper
• Metabolomics in cancer biomarker discovery: current trends and future perspectives.

  2014influential reference
• Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture

  2013influential reference
• Top down proteomics.

  2013influential reference
• A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics

  2013influential reference
• Molecular pathogenesis and progression of prostate cancer.

  2013cited by this paper
• Genomic Rearrangements of PTEN in Prostate Cancer

  2013cited by this paper
• The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.

  2013cited by this paper
• Current Status and Advances in Quantitative Proteomic Mass Spectrometry

  2013influential reference
• Novel parallelized quadrupole/linear ion trap/Orbitrap tribrid mass spectrometer improving proteome coverage and peptide identification rates.

  2013cited by this paper
• Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach

  2013influential reference
• IL 6 sensitizes prostate cancer to the antiproliferative effect of IFN a 2 through IRF 9

  2013cited by this paper
• Ovarian Cancer Biomarker Discovery Based on Genomic Approaches

  2013cited by this paper
• Prostate Cancer and the Search for Novel Biomarkers

  2013influential reference
• Protein analysis by shotgun/bottom-up proteomics.

  2013influential reference
• Mass Spectrometry for the Novice

  2013influential reference
• Prostate-specific antigen: any successor in sight?

  2013influential reference
• Usefulness of Traditional Serum Biomarkers for Management of Breast Cancer Patients

  2013cited by this paper
• Current Status of Biomarkers for Prostate Cancer

  2013influential reference
• Human Prostatic Acid Phosphatase: Structure, Function and Regulation

  2013cited by this paper
• The role of proteomics in prostate cancer research: biomarker discovery and validation.

  2013cited by this paper
• Management of prostate cancer : a multidisciplinary approach

  2012influential reference
• Glycans as cancer biomarkers.

  2012influential reference
• Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.

  2012cited by this paper
• Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges

  2012cited by this paper
• Prostate cancer and inflammation: the evidence

  2012influential reference
• Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos.

  2012influential reference
• Comparison of Next-Generation Sequencing Systems

  2012cited by this paper
• Emerging biomarkers of prostate cancer (Review)

  2012influential reference
• Benign prostatic hyperplasia: clinical manifestations and evaluation.

  2012influential reference
• Principles and Applications of LC-MS/MS for the Quantitative Bioanalysis of Analytes in Various Biological Samples

  2012cited by this paper
• The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer

  2012cited by this paper
• A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers

  2012cited by this paper
• Identification and Validation of Candidate Breast Cancer Biomarkers: A Mass Spectrometric Approach

  2012influential reference
• Serum metabolomics as a novel diagnostic approach for disease: a systematic review

  2012cited by this paper
• Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis-tandem mass spectrometry.

  2012cited by this paper
• Secreted proteins as a fundamental source for biomarker discovery

  2012cited by this paper
• Oncology biomarkers: discovery, validation, and clinical use.

  2012influential reference
• Serum proteomic analysis of prostate cancer progression

  2011influential reference
• Serum Early Prostate Cancer Antigen (EPCA) Level and Its Association with Disease Progression in Prostate Cancer in a Chinese Population

  2011cited by this paper
• Genomics and the continuum of cancer care.

  2011influential reference
• Mass Spectrometry-based Proteomics Using Q Exactive, a High-performance Benchtop Quadrupole Orbitrap Mass Spectrometer*

  2011cited by this paper
• IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.

  2011cited by this paper
• The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

  2011cited by this paper
• Prostate Cancer Screening

  2011cited by this paper
• Mass Spectrometry in Drug Metabolism and Disposition: Basic Principles and Applications

  2011cited by this paper
• Cancer biomarkers - current perspectives.

  2010influential reference
• Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: A form of communication during injury, infection, and cell damage

  2010cited by this paper
• The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.

  2010influential reference
• Cancer Biomarkers: Are We Ready for the Prime Time?

  2010influential reference
• Mass spectrometry–based proteomics in cell biology

  2010influential reference
• Blood and tissue biomarkers in prostate cancer: state of the art.

  2010influential reference
• The cancer cell secretome: a good source for discovering biomarkers?

  2010cited by this paper
• Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology

  2010influential reference
• Practical Aspects of Trapped Ion Mass Spectrometry, Volume IV : Theory and Instrumentation

  2010cited by this paper
• Proteomics: Challenges, Techniques and Possibilities to Overcome Biological Sample Complexity

  2009cited by this paper
• Benign Prostatic Hyperplasia and Its Aetiologies

  2009influential reference
• Synthesis of activated pyrimidine ribonucleotides in prebiotically plausible conditions

  2009cited by this paper
• The footprints of cancer development: Cancer biomarkers.

  2009influential reference
• Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

  2009cited by this paper
• Introduction to Mass Spectrometry:: Instrumentation, Applications, and Strategies for Data Interpretation

  2009cited by this paper
• Proteomics by mass spectrometry: approaches, advances, and applications.

  2009influential reference
• Emerging biomarkers for the diagnosis and prognosis of prostate cancer.

  2008influential reference
• Mass spectrometry and the emerging field of glycomics.

  2008cited by this paper
• Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

  2008cited by this paper
• Oncogenes and cancer.

  2008influential reference
• Mass spectrometry for proteomics.

  2008influential reference
• The Interleukin-8 Pathway in Cancer

  2008cited by this paper
• Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

  2008cited by this paper
• Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

  2008cited by this paper
• Hybrid mass spectrometers for tandem mass spectrometry

  2008cited by this paper
• The cancer secretome: a reservoir of biomarkers

  2008cited by this paper
• Biopsy Interpretation Of The Prostate

  2007influential reference
• PSA and other tissue kallikreins for prostate cancer detection.

  2007influential reference
• Genetic variability in inflammation pathways and prostate cancer risk.

  2007influential reference
• MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.

  2007cited by this paper
• Mechanisms of Disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate

  2007cited by this paper
• Metabolomic technologies and their application to the study of plants and plant-host interactions.

  2007cited by this paper
• Fundamentals of Contemporary Mass Spectrometry

  2007cited by this paper
• Orbitrap Mass Analyzer - Overview and Applications

  2006cited by this paper
• OMICS-driven biomarker discovery in nutrition and health.

  2006influential reference
• Verification of single-peptide protein identifications by the application of complementary database search algorithms.

  2006cited by this paper
• Urological oncology.

  2005cited by this paper
• Original article Associations between polymorphisms in the steroid 5- reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

  2005cited by this paper

• A Study Based on Mendelian Randomization: Exploring Blood Protein Ratios as Novel Diagnostic and Prognostic Indicators for Benign Prostatic Hyperplasia

  2024cites this paper